News & Analysis on Clinical Trial Services & Contract Research And Development
CluePoints: Citeline Award for Excellence in Innovation
By Jenni Spinner
- Last updated on
Study software provider CluePoints has received the Citeline Award for Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities. The award recognizes innovative work in developing new treatments, technologies, processes, services, or solutions to address the pandemic.
Patrick Hughes, CluePoints co-founder and chief commercial officer, said, “It is an absolute honor to receive this award in recognition of our pioneering work, which emphasizes the value of employing an agile, Risk-Based Quality Management (RBQM) approach. Thanks to the implementation of CluePoints’ solutions, the Pfizer/BioNTech product became the first COVID-19 vaccine to receive regulatory approval just 266 days after the pandemic declaration – and hundreds of millions of doses have since been administered around the globe.”